235 related articles for article (PubMed ID: 26898301)
1. The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A.
Chen YT; Zhu F; Lin WR; Ying RB; Yang YP; Zeng LH
Cancer Chemother Pharmacol; 2016 Apr; 77(4):757-65. PubMed ID: 26898301
[TBL] [Abstract][Full Text] [Related]
2. [Effect of a novel EZH2 inhibitor GSK126 on prostate cancer cells].
Lin W; Chen Y; Zeng L; Ying R; Zhu F
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):356-363. PubMed ID: 27868408
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
Huang B; Huang M; Li Q
Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
Zhang P; de Gooijer MC; Buil LC; Beijnen JH; Li G; van Tellingen O
Int J Cancer; 2015 Oct; 137(8):2007-18. PubMed ID: 25868794
[TBL] [Abstract][Full Text] [Related]
6. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
[TBL] [Abstract][Full Text] [Related]
7. Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.
Zeng D; Liu M; Pan J
Oncotarget; 2017 Jan; 8(2):3396-3411. PubMed ID: 27926488
[TBL] [Abstract][Full Text] [Related]
8. Long residence time inhibition of EZH2 in activated polycomb repressive complex 2.
Van Aller GS; Pappalardi MB; Ott HM; Diaz E; Brandt M; Schwartz BJ; Miller WH; Dhanak D; McCabe MT; Verma SK; Creasy CL; Tummino PJ; Kruger RG
ACS Chem Biol; 2014 Mar; 9(3):622-9. PubMed ID: 24304166
[TBL] [Abstract][Full Text] [Related]
9. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
10. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
11. A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
Sarma P; Ramaiah MJ; Pal D; Bhadra U; Pal Bhadra M
Life Sci; 2016 Apr; 151():264-276. PubMed ID: 26979778
[TBL] [Abstract][Full Text] [Related]
12. Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
Adhikary G; Grun D; Balasubramanian S; Kerr C; Huang JM; Eckert RL
Carcinogenesis; 2015 Jul; 36(7):800-10. PubMed ID: 25969142
[TBL] [Abstract][Full Text] [Related]
13. PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia.
Zhou J; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Dai W; Wang Y; Jin Y; Pan J
Clin Cancer Res; 2018 Jan; 24(1):145-157. PubMed ID: 29070525
[No Abstract] [Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
[TBL] [Abstract][Full Text] [Related]
16. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
[TBL] [Abstract][Full Text] [Related]
17. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
19. GSK126 alleviates the obesity phenotype by promoting the differentiation of thermogenic beige adipocytes in diet-induced obese mice.
Wu X; Wang Y; Wang Y; Wang X; Li J; Chang K; Sun C; Jia Z; Gao S; Wei J; Xu J; Xu Y; Li Q
Biochem Biophys Res Commun; 2018 Jun; 501(1):9-15. PubMed ID: 29654753
[TBL] [Abstract][Full Text] [Related]
20. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
